proactiveinvestors.comSEP 292 min read$BHST

BioHarvest Sciences launches buyback of up to 5% of shares

BioHarvest Sciences Inc (BHST) announced a share repurchase program for up to 5% of its outstanding shares, or 1,133,392 shares. The board believes the market price may not reflect the company's value and growth prospects. CEO Zaki Rakib highlighted the company's evolution and potential revenue streams.

Original reporting

proactiveinvestors.com

Published Sep 29, 2026, 8:40 AM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 29, 2026, 3:17 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

BioHarvest Sciences launches buyback of up to 5% of shares — source image — Source · proactiveinvestors.com

Decision brief

The 30-second read

$BHSTBullishMed

Why it matters

The buyback announcement provides a fresh catalyst that may improve short‑term price dynamics.

Market read

A new buyback program for a micro‑cap biotech could attract short‑term buying interest and modestly lift the stock.

What to watch

Execution risk of the bid and potential dilution from future financing needs.

Relevance 6/10Novelty 6/10Timing: effective today

Background

BioHarvest Sciences develops plant‑based compounds for various industries and recently expanded beyond its VINIA platform.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$BHSTBullishMedium confidence

Context

Board authorized a share repurchase program up to 5% of outstanding shares, max 1,133,392 shares.

Expected impact

likely upward pressure as market prices in the repurchase.

Evidence & confidence

The program size is modest for a micro‑cap, but buybacks are generally viewed favorably and can lift sentiment.

Market effects

Sector

Highlights growing interest in plant‑based biotech, may boost peer sentiment.

Regional

Limited to US‑listed biotech micro‑caps.

Global

Low; primarily affects BHST shareholders.

Counterpoint

What could challenge this read

Buyback could be a defensive move masking limited growth prospects.

Key entities

Company
BioHarvest Sciences Inc
NASDAQ‑listed biotech firm focusing on plant‑based molecules.
Executive
Dr Zaki Rakib
CEO of BioHarvest Sciences, quoted on the buyback rationale.

Read at source ← All news

OCT 13

$GETYMed

Small cap wrap: Renforth Resources, Digi Power X, BioHarvest, Namibia Critical

Getty Images (NYSE:GETY) plans to file for bankruptcy under a $533M deal. Navitas (NASDAQ:NVTS) reiterated 'outperform' due to Nvidia collaboration. Cipher Digital (NASDAQ:CIFR) fell 11% on $850M convertible notes plan. BioHarvest (NASDAQ:BHST) ready to license Olive Cell. Namibia Critical Metals (TSX-V:NMI) nearing JV approval. Digi Power X (NASDAQ:DGXX) secures $200M debt financing. Renforth Resources (CSE:RFR) reports gold in Parbec deposit.

proactiveinvestors.com2 min

OCT 13

$CIFRMed

MARKETS LIVE: US stocks trade mixed as chipmakers weigh on markets

US stocks traded mixed as chipmakers weighed on markets. Cipher Digital (CIFR) fell 11% on $1B convertible notes plan. BioHarvest (BHST) ready for commercial licensing. Enerflex (EFX) rose 13% on $1B+ contract. Getty Images (GETY) seeks Chapter 11 under $533M restructuring. Domino’s (DPZ) beat EPS estimates but US same-store sales grew just 0.3%. Bumble (BMBL) agreed to $1.3B takeover. J&J (JNJ) raised 2026 forecasts. Citigroup (C) and Wells Fargo (WFC) reported better-than-expected earnings.

proactiveinvestors.com7 min

SEP 3

$AVGOMed

Dow climbs as stocks rebound on earnings, falling Treasury yields

Tiziana Life Sciences (TLSA) received a Buy rating and $7 price target from BTIG. Ocean Power Technologies (OPTT) is using Palantir Foundry to improve operations. Sintana Energy (SEI) reported TotalEnergies' acquisition of a 40% interest in Namibia’s PEL 83. American Resources (AREC) joined the Critical Minerals Institute. Thistle Resources (TRCG) launched a Phase 3 drill program. BioHarvest Sciences (BHST) plans to dual-list on the Tel Aviv Stock Exchange. Alvopetro Energy (ALV) reported August

proactiveinvestors.com3 min

AUG 13

$BHSTMed

BioHarvest Sciences Q2 Earnings Call Highlights

BioHarvest Sciences (NASDAQ:BHST) reported Q2 gross profit of $5.1M and a net loss of $3.7M ($0.17/share). Cash was $16.2M at June 30. 2026 revenue guidance was cut to $37M-$40M and EBITDA loss to $3M-$5M. Management tightened CDMO revenue to $4M-$5M and reduced VINIA outlook to $33M-$35M.

yahoo.com6 min

AUG 12

$BHSTMedAI 8/10

BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript

BioHarvest Sciences (BHST) reported Q2 2026 revenue of $8.8 million, up 3.8% year over year, with gross profit of $5.1 million and a net loss of $3.7 million ($0.17/share). Cash rose to $16.2 million. The company revised 2026 revenue guidance to $37 million to $40 million and expects consolidated EBITDA losses of $3 million to $5 million, citing a shift toward CDMO growth and a rare fragrance supply agreement.

fool.com6 min

AUG 11